David E Anderson

Chief Scientific Officer VBI Vaccines & HDT Bio

Seminars

Thursday 19th February 2026
Advancing the Use of Cancer Vaccines in Glioblastoma to Reprogram the Patient’s Immune System
4:30 pm
  • Discussing the importance of tumor antigen selection and balanced immunity in vaccine design
  • Addressing the tumor microenvironment to enhance cancer vaccines
David Anderson, speaking at 7th Glioblastoma Drug Development Summit